IP Library Granted Patent US 11,806,533
Granted Patent B2
US 11,806,533 · App. 16/842,863 · Granted Nov 7, 2023

Systems and methods related to the treatment of back pain

Inventors: Meredith McGee (Cary, NC); Joseph W. Boggs (Carrboro, NC); John Chae (Strongsville, OH); Amorn Wongsarnpigoon (Chapel Hill, NC); Maria E. Bennett (Beachwood, OH)
Assignee: SPR Therapeutics, INC.
A61N1/36071A61N1/0551A61N1/0558A61N1/36017A61N1/36021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,806,533
App. No.
16/842,863
Granted
Nov 7, 2023
Kind
B2
Abstract

The present invention reduces pain and improves function long-term in persons with back pain using electrical stimulation in the back. This approach involves an electrical stimulation device including at least one electrode adapted for insertion within an animal body with back pain and at least one pulse generator operatively coupled with the at least one electrode, wherein the pulse generator delivers electrical stimulation activating at least a nerve innervating at least a paraspinal muscle in a back of the animal body for pain relief.

Claims (29)

1. An electrical stimulation device comprising:

a monopolar electrode adapted for insertion within an animal body;

a percutaneous lead operatively coupled with the monopolar electrode; and

an external pulse generator operatively coupled with the electrode through the percutaneous lead, wherein the pulse generator delivers electrical stimulation to peripheral nerves generating neurally encoded signals in afferent nerve fibers to evoke changes in central processing of pain without stimulation of muscles at a level necessary to cause functional changes.

2. The electrical stimulation device of claim 1 , wherein the percutaneous lead is a coiled lead.

3. The electrical stimulation device of claim 1 , wherein the percutaneous lead includes an insulated portion and a deinsulated portion whereby the deinsulated portion forms the monopolar electrode.

4. The electrical stimulation device of claim 3 , wherein the percutaneous lead includes a barb formed from the deinsulated portion.

5. The electrical stimulation device of claim 3 , wherein the percutaneous lead includes a taper between the insulated portion and deinsulated portion.

6. The electrical stimulation device of claim 1 , wherein the pulse generator is wirelessly powered.

7. The electrical stimulation device of claim 1 , wherein the generator comprises a housing with a clip configured to attach to a belt.

8. The electrical stimulation device of claim 1 , wherein the pulse generator comprises a display.

9. The electrical stimulation device of claim 1 , wherein the pulse generator comprises a user control.

10. The electrical stimulation device of claim 9 , wherein the user control comprises an increment switch, a decrement switch, and a select switch.

11. The electrical stimulation device of claim 10 , wherein the increment and decrement switches cycle through operational modes.

12. The electrical stimulation device of claim 10 , wherein the select switch is used to display different operational patterns of the electrical stimulation.

13. The electrical stimulation device of claim 10 , wherein the select switch is a power on/off toggle switch.

14. The electrical stimulation device of claim 1 , wherein the percutaneous lead is fabricated from a 7-strand stainless steel wire insulated with a biocompatible polymer.

15. The electrical stimulation device of claim 1 , wherein the pulse generator comprises a microprocessor-based stimulation pulse generator circuit with a micro controller.

16. An electrical stimulation device comprising:

a monopolar electrode adapted for insertion within an animal body;

a percutaneous lead operatively coupled with the monopolar electrode; and

an external pulse generator operatively coupled with the electrode through the percutaneous lead, wherein the pulse generator delivers electrical stimulation activating peripheral nerves and paraspinal muscles generating neurally encoded signals in afferent nerve fibers to evoke changes in central processing of pain-without mechanical stabilization.

17. The electrical stimulation device of claim 16 , wherein the pulse generator comprises an increment switch, a decrement switch, and a select switch.

18. The electrical stimulation device of claim 17 , wherein the increment and decrement switches cycle through operational modes, the select switch is used to display different operational patterns and the select switch is a power on/off toggle switch.

19. The electrical stimulation device of claim 16 , wherein the percutaneous lead is fabricated from a 7-strand stainless steel wire insulated with a biocompatible polymer.

20. An electrical stimulation device comprising:

at least one electrode adapted for insertion below skin of an animal body; and

an external pulse generator operatively coupled with the at least one electrode, wherein the pulse generator delivers electrical stimulation for a prescribed period of time to activate peripheral nerves of the dorsal ramus in a back of the animal body to generate neurally encoded signals in afferent nerve fibers to evoke changes in central processing of pain without stimulation of muscles at a level necessary to cause functional changes.

21. The electrical stimulation device of claim 20 , wherein the pulse generator comprises a microprocessor-based stimulation pulse generator circuit with a micro controller.

Assignments (3)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2020
From: MCGEE, MEREDITH; BOGGS, JOSEPH W.; CHAE, JOHN; WONGSARNPIGOON, AMORN; BENNETT, MARIA E.
To: SPR THERAPEUTICS, INC.
Reel/Frame 052339/0201 →